New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI)
PHILADELPHIA, May 22 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY ), the global specialty biopharmaceutical company, announced results of a study showing that coadministration of the ADHD medication
VYVANSE(R) (lisdexamfetamine dimesylate) CII with the proton pump inhibitor (PP...
VIDEO from Medialink and the Epilepsy Foundation: New Study Suggests Different Versions of the Same Epilepsy Medication Can Be Harmful
WASHINGTON, May 12 /PRNewswire/ -- The Epilepsy Foundation recently announced findings that show people with epilepsy, whose seizures have been controlled with a consistent drug therapy, have a greater chance of increased seizures, greater side effects or sudden death when their medications are sw...
CareHere's Electronic Medication System Proves 100 Percent Effective in Response to Recall
NASHVILLE, Tenn., April 16 /PRNewswire/ -- When the U.S. Food and Drug Administration (FDA) issued a recall of a widely used heart medication
last month, CareHere's proprietary medication
tracking system allowed the company to instantly generate a list of all patients taking the medication. For...
American Lung Association Study to be Published in the 'New England Journal of Medicine' Finds Prescription Heartburn Medication Does Not Control Asthma Symptoms as Previously Thought
--Practice Changing Study Calls on Doctors to Stop Prescribing Potent Heartburn Medications to Asthma Patients Without Frequent Symptoms of Gastric Reflux--
WASHINGTON, April 8 /PRNewswire-USNewswire/ -- For nearly 20 years, it was believed that severe asthma symptoms such as coughing, wheezi...
Parkinson's Disease Medication Triggers Destructive Behaviors
Mayo Clinic Study Identifies At-Risk Patients
*Parkinson's drug may cause destructive behaviors
*The patients affected are taking a therapeutic dose of the drug
*Decreasing the dosage may eliminate the problem
ROCHESTER, Minn., April 8 /PRNewswire-USNewswir...
Aching Back? Cholesterol Medication Might Help
Study finds that using statins may be useful in treatment for degenerative disc disease
LAS VEGAS, Feb. 22 /PRNewswire-USNewswire/ -- Back pain, a hallmark of degenerative disc disease, sends millions of people to their doctor. In fact, more than 80 percent of patients who undergo spine surg...
Fertility Physicians of Northern California Researchers Test New Forms of Progesterone Medication for Luteal Support During IVF
SAN JOSE, Calif., Jan. 5 /PRNewswire/ -- Women undergoing in vitro
fertilization (IVF) require progesterone medication
to help support early
pregnancy, but the intramuscular injections for some forms of this medication
can be painful for patients. Formulations of progesterone medication
Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer
SAN FRANCISCO, Dec. 7 /PRNewswire-USNewswire/ -- The largest study ever to examine the preventive use of blood-thinning medication
to help prevent deadly blood clots in patients with cancer undergoing chemotherapy will be presented in a press conference on Sunday, December 7, at 9:30 a.m., during ...
FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder
PHILADELPHIA, Nov. 20 /PRNewswire-FirstCall/ --GlaxoSmithKline (NYSE: GSK ) today announced that the United States Food and Drug Administration (FDA) granted accelerated approval for PROMACTA(R) (eltrombopag) for the treatment of thrombocytopenia in patients with chronic immu...
Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkin's Lymphoma
Study Reports 92 Percent Response Rate to Combination Treatment
FRAZER, Pa., July 15 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq:
CEPH) announced today that in a phase 2 study published online today in the
Journal of Clinical Oncology, 92 percent of patients with relapsed indolent
Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone
-- Clinical trial data for Perforomist(TM) (Formoterol Fumarate) Inhalation Solution presented at International ATS Conference --
NAPA, Calif., May 20 /PRNewswire/ -- Data presented today at the
International Conference of the American Thoracic Society (ATS) demonstrate
that concomitant ...
More Than 1.5 Million Americans Sickened, Injured or Killed by Medication Errors Each Year; Seniors Most at Risk
DailyMed(TM) Launches Innovative Solution to Medication
NEW YORK, Jan. 28 /PRNewswire/ -- Acute consequences of medication
mismanagement continue to mount, emphasizing the urgent need for a
systematic change in the way we care for the 38+ ...
Addrenex Pharmaceuticals Reports Positive Results in Second Phase 3 Study of ADHD Medication
Study shows Clonicel(R) and stimulants combined provide greater improvement in symptoms than stimulants alone
DURHAM, N.C., April 23 /PRNewswire/ -- Addrenex Pharmaceuticals, Inc. today announced positive results from a second phase 3 trial of Clonicel demonstrating that the combination of Cl...
Study Sheds Light on Medication Treatment Options for Bipolar
BETHESDA, Md., March 29, 2007--For depressed people with bipolar
disorder who are taking a mood stabilizer, adding an antidepressant
medication is no more effective than a placebo (sugar pill),
according to results published online on March 28, 2007 in the New
England Journal of Medicine. The resu...
New Anti-Rejection Medication 6-Month Results for Heart Transplant
Recipients to Be Released at International Heart and Lung
ADDISON, Texas, April 19, 2007 /PRNewswire/ -- New clinical
trial results for heart transplant patients will be released at the
upcoming International Society for Heart and Lung Transplantation
(ISHLT) 27th Annual Meeting and Scientific Sessions at the Hilton
San Francisco, April 25-28, 2007. Resu...
Separate Sets of Research Show Treatment Improved Quality of Life
in as Early as Three Weeks; Patient Adherence to Medication is
WASHINGTON, May 22, 2007 /PRNewswire/ -- Results from analyses
looking at factors contributing to successful treatment of
ulcerative colitis (UC), were presented at Digestive Disease Week
(DDW) this week. Both of these studies were funded by Procter &
Gamble (P&G) Pharmaceuticals, Inc. Fin...
Shire Announces Positive Results of Studies With Guanfacine
Extended Release, An Investigational Nonstimulant Medication Filed
for the Treatment of ADHD in Children and Adolescents
SAN DIEGO, May 23, 2007 /PRNewswire-FirstCall/ -- Shire plc
announced today the positive results of studies of the
guanfacine extended release (GXR,
previously referred to as SPD503), a selective
alpha-2A-adrenoceptor agonist. These data from two short-term phase
Next Safety, Inc.'s Innovative Drug Delivery System Will Replace
Cigarettes and Significantly Advance Pulmonary Medication Delivery
WEST JEFFERSON, N.C.--(BUSINESS WIRE)--Jun 15, 2007 - Next Safety,
Inc. has identified basic scientific mechanisms that promise to
revolutionize pulmonary drug delivery. This proprietary technology
uses a stream of purified air to deliver medications deep into the
pulmonary system. It is considered...
Stanford Study Finds No Conclusive Benefit From Treating
Kleptomania With Medication
STANFORD, Calif.--(BUSINESS WIRE)--Mar 15, 2007 - A small clinical
trial of a medication
to treat kleptomania has failed to find any
conclusive benefit for patients with the impulsive stealing
disorder, according to researchers at the Stanford University
School of Medicine.
But the results leave o...
Drug for Treatment of Heart Failure Does Not Improve Survival,
Compared to More Widely-used Medication
CHICAGO, May 1, 2007—The drug levosimendan did not improve
survival for patients with decompensated heart failure when
compared with a more widely-used treatment for this condition,
dobutamine, according to a study in the May 2 issue of
Acute decompensated heart failure (ADHF; seve...
New Data Focuses on Abuse of Stimulant Medication
New Data Suggests Less Abuse-Related Effects For OROS(r)
Two New Studies Highlight Potential Benefit of Unique OROS(r)
SAN DIEGO, CA, May 22, 2007 - Stimulant drug abuse remains an
ongoing concern for parents and physicians who prescribe
medications to treat Attenti...
Tiny Cup Attached to Eye Improves Drug Delivery For Retinal Diseases
...ch like an organ-specific transdermal skin patch, the tiny cup isolates the medication
targeted to the eye from being absorbed into the blood stream. This new del...implantation of this kind of device on any organ and the ability to deliver medication
to the affected organ, could be a huge advance in how we currently treat ca...
Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia
...ed with an oral atypical antipsychotic miss taking medication
for about one-third of the year (110 days).(3) The...me, a definitive monitoring tool for uninterrupted medication
compliance, which may help optimize clinical outco...help healthcare professionals address the issue of medication
adherence and can also help many patients delay th...
Popular Breast Cancer Drug Used with Certain Antidepressants Puts New Jersey Women at Risk
...s Willingboro, N. J. pharmacy. "Women taking tamoxifen along with an SSRI should speak with their doctor immediately to discuss modifications to their medication
regimen to ensure they are getting the full benefit of their tamoxifen therapy."
Approximately 500,000 women take tamoxifen in the U.S., with 8...
Is Your Hair Taking a Break?
...their full length or diameter.
Fortunately, several treatment options are effective for women with hair loss. Minoxidil 2% is the only topical medication
approved by the U.S. Food and Drug Administration (FDA) for female-pattern hair loss. Minoxidil 5% is only FDA-approved for male-pattern hair loss, bu...
Economy is Driving Many Osteoporotic Women to Retire Later - But Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease
...sus 44 percent)
More than a quarter (27 percent) of the survey respondents reported that they often do not take their osteoporosis medication
Only a little more than one-third (35 percent) of women reported initiating discussion of the disease with their doctor
S.C. Medical Home Pilot for Diabetes Enrolls 1,110
...ts" with a physician.
The case managers aim to reduce gaps in care, such as missed appointments with specialists, and lifestyle issues such as medication
adherence. They also perform outreach, such as registering patients for diabetic education, scheduling appointments with specialists, providing discou...
R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies - Results Incongruent
... methodology, was 3.2-3.6 mmHg for the 100 mg bid dose group. In TASKi3, approximately 17% of patients in the 100 mg bid dose group had blood pressure medication
adjusted or in some cases initiated during the course of the clinical trial, compared to 8% of the placebo patients. For those patients who had their...
Takeda Provides Update on the Investigational Fixed-Dose Combination of alogliptin and ACTOS(R) (pioglitazone HCl)
...ety trial that satisfies the December 2008 FDA Guidance for alogliptin.
About ACTOS ((R)) (pioglitazone HCl)
ACTOS is a prescription medication
used with diet and exercise to improve blood sugar (glucose) control in adults with type 2 diabetes. ACTOS is not for patients with type 1 "juvenile" ...
Lilly and New York City Mayor Michael R. Bloomberg Announce Lilly Agrees to be First Tenant of East River Science Park; Issue Urgent Call for Healthcare Reform that Protects Innovation and Jobs
...hs annually. Current medical techniques for the treatment of gastric cancer are primarily palliative rather than curative. There is an urgent need for medication
that can do more than simply cloak the effects of this disease."
Continuing Innovation Critical
When it moves to the new East River Sci...
July 2009 Mayo Clinic Women's HealthSource Highlights Food Storage Safety, Energy Therapies and Vitamins and Minerals
... for these effects, usually greater than 1,000 milligrams (mg) per day, can cause liver damage. High doses of niacin should be considered a prescribed medication
and taken only under a doctor's supervision.
Vitamin C: Studies have shown that eating food high in vitamin C can lower rates of cancer an...
CareFirst BCBS Covers eNO Measurement for Diagnosis, Asthma Treatment
...adopters of eNO monitoring have reported that eNO is predictive of asthma in patients with normal lung function, predictive of lack of compliance with medication
regimens, and predictive of response to inhaled corticoid steroids," said Ms. Holly McGarraugh, Apieron CEO & President. "We are delighted that Ca...
FDA Approves Tekturna HCT(R) as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent
...nation of Tekturna and HCTZ offered greater blood pressure reductions than either drug alone.
"Up to 85% of patients will need more than one medication
to reach their blood pressure goals," said Alan Gradman, MD, Cardiologist at The Western Pennsylvania Hospital and Professor of Medicine at Temple Uni...
Elbit Imaging Ltd. Announces - Swiss Team Uses InSightec's ExAblate(R) 4000 Brain System to Treat Patients With Functional Brain Disorders
...asive deep brain ablation surgery (central lateral
thalamotomy) with transcranial TcMRgFUS and showed improvement in pain scores
and reduction of pain medication
with no adverse effects at three months
follow-up. This is the first study in the world to test non-invasive
transcranial focused ultrasound as a trea...
Rigel's R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial
... 150 mg qd and the 100 mg bid dose groups, respectively, had blood pressure medication
adjusted or in some cases initiated during the course of the study, compare... +0.6/+1.4
Mean Systolic BP if had Adjustment or Initiation of BP medication
# Had BP Meds Adjusted/Initiated 11 (7%) 27 (18%) ...
Procter & Gamble Pharmaceuticals Launches Asacol(R) HD (mesalamine) Delayed-Release Tablets
...al bleeding, abdominal cramping and an urgent need to go to the bathroom. Flares can vary in duration and intensity. While UC is a lifelong condition, medication
may help control flares.
UC affects people of all ages, but is often diagnosed during early adulthood. The causes of this condition are unknown, ...
New AHRQ Study Finds Mixed Evidence on Use of Radiofrequency Catheter Ablation for Treating Atrial Fibrillation
...an 2.2 million Americans, putting them at risk for heart failure, blood clots, or stroke. Patients with atria fibrillation are typically treated with medication
first, but medicines only work for about half of patients for preventing recurrence of atrial fibrillation.
The report calls for more research on...
Current Status of the Development Programs of New Indications and Formulations for Aricept(R) for Enhancing Patient Value
...with Teikoku Seiyaku Co., Ltd. and its U.S. subsidiary, Teikoku Pharma USA, Inc.
Aricept is the first and only prescription medication
approved by the U.S. Food and Drug Administration for mild, moderate and severe dementia of the Alzheimer's type. This indication is supported by evi...
PARI LC Plus and PRONEB Ultra Used in Two Perforomist Studies on Improving COPD Therapies
... maintenance treatments for COPD. Sutherland et al. used an open-label crossover design allowing researchers to catalog patient preferences regarding medication
delivery. Patients felt greater treatment satisfaction and perceived better control of their COPD with nebulized formoterol fumarate delivered by PAR...
AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain
...gesic gaps due to infiltrated and dislodged IV catheters. Additionally, the complexity and programmability of IV PCA pumps introduce opportunities for medication
errors, which in some instances may be fatal.
About ARX-01 Sufentanil NanoTab PCA System
ARX-01 is a novel drug/device combination product ca...